Citations

Institution: Mayo Clinic Clear

Showing 10 of 108094 citations.

Sudden cardiac death secondary to acute aortic syndromes in young athletes in the United States
Petek, Bradley J. , Moulson, Nathaniel , Kliethermes‌, Stephanie , Maleszewski, Joseph J. , Drezner, Jonathan A. , Churchill, Timothy W. , Drezner, Jonathan A , Churchill, Timothy W , Kliethermes, Stephanie A , Baggish, Aaron L. , Delong, Randi , Kucera, Kristen L. , Harmon, Kimberly G.

European Journal of Preventive Cardiology | July 30, 2025 | Volume: 33 | Issue: 8 | Pages: 1499-1501

10.1093/eurjpc/zwaf472 | PMID 40737489 Get It

Advances in the management of osteoporosis
Hoong, Caroline Wei Shan , Saul, Dominik , Khosla, Sundeep , Sfeir, Jad

BMJ | July 30, 2025 | Volume: 390 | Issue: No issue available | Pages: e081250

10.1136/bmj-2024-081250 | PMID 40738610 Get It

ABSTRACT Osteoporosis is a chronic disease mainly prevalent in older people. A hip fracture, its most devastating complication, is associated with a one in five chance of mortality in the first year. This review discusses emerging risk factors for bone fragility including diabetes, sarcopenia, and bariatric surgery. Recency of fracture represents an imminent risk that deserves prompt recognition. The new FRAXplus calculator accounts for additional risk factors to refine existing risk stratification. Advances in imaging techniques such as trabecular bone score and radiofrequency echographic multi-spectrometry may have potential roles in specific populations. Treatment of osteoporosis requires a multifaceted approach. Non-drug interventions include fall prevention and resistance exercises, supplementation with calcium, vitamin D and possibly vitamin K, and effective bridging of care gaps with fracture liaison services. An overview of drug therapy is provided, drawing attention to the importance of sequential therapy starting with potent anabolic agents for the patients at the highest risk, as opposed to a traditional step-up approach. An individualized, goal directed care plan is necessary for a treat-to-target approach, with total hip bone mineral density being the best specific target. Future research in cellular senescence points to the role of senolytics and senomorphics to alleviate osteoporosis, among other age related conditions.
Sex disparities in in-hospital treatments, outcomes, and resource utilization among peritoneal dialysis patients: A nationwide inpatient sample analysis
Thongprayoon, Charat , Kaewput, Wisit , Wathanavasin, Wannasit , Davis, Paul W. , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Kaewput, Wisit , Thongprayoon, Charat , Wathanavasin, Wannasit , Suppadungsuk, Supawadee , Tangpanithandee, Supawit

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis | July 30, 2025 | Volume: 46 | Issue: 3 | Pages: 213-222

10.1177/08968608251362904 | PMID 40734568 Get It

Background Sex-based differences may influence the clinical management, complication risks, and healthcare resource utilization of hospitalized end-stage kidney disease (ESKD) patients undergoing peritoneal dialysis (PD). Understanding these disparities is essential for optimizing patient care and informing healthcare policy. Methods This study was conducted using the National Inpatient Sample to identify hospitalized adult ESKD patients receiving PD from the year 2003 to 2018. The outcomes included 1) PD-related outcomes, defined as a composite of peritonitis, mechanical complications, catheter removal or revision, and adequacy issues, 2) non-PD-related outcomes, defined as a composite of sepsis, cardiac arrest, and need for mechanical ventilation 3) transfer to hemodialysis, and 4) in-hospital mortality. The associations between sex and in-hospital outcomes were analyzed using multivariable logistic regression and were adjusted for demographic factors, comorbidities, primary diagnoses, admission types, and hospital characteristics. Discharge weights were applied to generate nationally representative estimates. Results Of 97,036 hospitalized ESKD patients receiving PD analyzed, 48,906 (50.4%) were females. In adjusted analyses, there were no overall sex differences in PD-related outcomes, non-PD-related outcomes, or in-hospital mortality. However, age- and comorbidity-based variations were observed in PD-related outcomes. Female sex was associated with lower odds of transfer to hemodialysis, particularly among younger patients and those without heart failure or peripheral vascular disease. Notably, sex differences in in-hospital mortality were observed only among patients with elective admissions. Conclusion There were sex-based disparities in the outcomes and healthcare utilization of hospitalized ESKD patients receiving PD. These findings underscore the need for sex-specific, individualized strategies to improve PD care and inform clinical and policy decisions.
Computed Tomography and Coronary Plaque Analysis
AlHammouri, Hashim M. , Ibrahim, Ramzi , Al-Asmar, Rahmeh, Abdelnabi, Mahmoud , Habib, Eiad , Allam, Mohamed , Pham, Hoang Nhat , Elbenawi, Hossam , Farina, Juan M. , Tamarappoo, Balaji , Jokerst, Clinton, Ayoub, Chadi , Arsanjani, Reza , Alhammouri, Hashim , Farina, Juan M , Arsanjani, Reza , Allam, Mohamed N , Nhat, Hoang , Ibrahim, Ramzi , Al-Asmar, Rahmeh , Lee, Kwan

Tomography | July 30, 2025 | Volume: 11 | Issue: 8 | Pages: 85

10.3390/tomography11080085 | PMID 40863876 Get It

Advances in plaque imaging have transformed cardiovascular diagnostics through detailed characterization of atherosclerotic plaques beyond traditional stenosis assessment. This review outlines the clinical applications of varying modalities, including dual-layer spectral CT, photon-counting CT, dual-energy CT, and CT-derived fractional flow reserve (CT-FFR). These technologies offer improved spatial resolution, tissue differentiation, and functional assessment of coronary lesions. Additionally, artificial intelligence has emerged as a powerful tool to automate plaque detection, quantify burden, and refine risk prediction. Collectively, these innovations provide a more comprehensive approach to coronary artery disease evaluation and support personalized management strategies.
Predicting Symptomatic Response to Prokinetic Treatment Using Gastric Alimetry
Varghese, Chris , Hove, Sibylle Van, Schamberg, Gabriel , Wu, Billy, Poonawala, Nooriyah, Law, Mikaela , Dachs, Nicky , Johnston, Gen, Fitt, India, Foong, Daphne , Andrews, Christopher N. , O’Grady, Gregory , Parkman, H P , Abell, T L , O'Grady, Gregory , Varghese, Chris , Schamberg, Gabriel , Johnston, Gen, Parkman, Henry P. , Abell, Thomas L. , Ho, Vincent , Calder, Stefan , Gharibans, Armen A. , Andrews, Christopher N.

Neurogastroenterology & Motility | July 30, 2025 | Volume: 37 | Issue: 11 | Pages: No page available

10.1111/nmo.70132 | PMID 40734520 Get It

ABSTRACT Background Chronic neurogastroduodenal disorders are challenging to manage, with therapy often initiated on a trial and error basis. Prokinetics play a significant role in management, but responses are variable and have been associated with adverse events, impacting widespread use. We investigated whether body surface gastric mapping (BSGM) biomarkers (using Gastric Alimetry) could inform patient selection for prokinetic therapy. Methods Patients with chronic gastroduodenal symptoms taking oral prokinetic agents, regardless of gastric emptying status, were prospectively recruited and underwent BSGM (30 m baseline, 482 kcal standardized meal, 4 h postprandial recording) while off‐prokinetic agents. Patients were followed up with daily symptom diaries. A subset was compared to matched patients not taking prokinetic agents. Prokinetic responders were defined based on symptom improvement greater than a minimum clinically important difference methodology. Key Results Forty‐two patients (88% female; median age 36; median BMI 26) taking prokinetics were analyzed. Prokinetic prescribing, compared to matched patients, was independent of BSGM metrics ( p > 0.15). In patients on existing prokinetics (withheld for BSGM), lower amplitudes predicted reduced symptom burden, whereas low rhythm stability predicted a worse symptom burden ( p < 0.05). In prokinetic‐naive patients (i.e., started on a prokinetic during the study), a lower postprandial amplitude predicted responders (mean 37.5 ± 10.6 uV in responders [ n = 5] vs. mean 54.8 ± 6.6 uV among nonresponders [ n = 3], p = 0.047). Conclusions Gastric Alimetry biomarkers may help in the prediction of prokinetic response in patients with chronic gastroduodenal symptoms. Lower postprandial amplitudes, indicating a reduced meal response, appear to predict benefit, while impaired rhythm stability predicted poorer therapeutic response.
Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists
Sangoi, Ankur R. , Mubeen, Aysha , Humble, Robert , Wu, Douglas, Amin, Mahul, Aron, Manju , Brimo, Fadi , Chan, Emily , Cheng, Liang, Cheville, John C. , Collins, Katrina, Cornejo, Kristine M. , Downes, Michelle R. , Epstein, Jonathan I. , Hirsch, Michelle S. , Mohanty, Sambit K. , Netto, George J. , Osunkoya, Adeboye O. , Paner, Gladell P. , Rao, Priya, Smith, Steven C. , Tickoo, Satish K. , Tretiakova, Maria , Trpkov, Kiril , Wobker, Sara E. , Tamboli, Pheroze, Zynger, Debra L. , Cheng, Liang , Collins, Katrina , Cheng, Liang , Sangoi, Ankur R , Tretiakova, Maria S , Trpkov, Kiril , Akgül, Mahmut , Pacheco, Richard R. , Acosta, Andrés , Amin, Mahul, Dhillon, Jasreman , Kapur, Payal , Lobo, Anandi , Mehra, Rohit, Saleeb, Rola , Shah, Rajal B. , Shen, Steven S. , Tamboli, Pheroze, Williamson, Sean R.

American Journal of Surgical Pathology | July 30, 2025 | Volume: 49 | Issue: 12 | Pages: 1307-1314

10.1097/pas.0000000000002456 | PMID 40734292 Get It

Pelvicalyceal invasion (PCI) is a relatively novel pT3a staging parameter for renal cell carcinoma (RCC) nephrectomies. While interobserver reproducibility staging studies of sinus/vascular invasion in RCC exist, a similar evaluation for PCI has not been performed. Moreover, in our experience, there is also diagnostic variability in how pathologists interpret PCI. Herein, we explore interobserver reproducibility among genitourinary (GU) pathologists. Twenty hematoxylin and eosin-stained digitized slides from RCCs (all grossly approaching the renal pelvis) were distributed to 31 GU pathologists to classify each as PCI or not PCI based on their respective clinical practices; slides with concomitant sinus/fat/vascular invasion were excluded. Slides were then evaluated for the following 4 morphologic features: tumor abutting renal pelvis, tumor pushing/indenting into the renal pelvis, polypoid configuration of tumor into the renal pelvis, and tumor eroding through renal pelvic urothelium. Interobserver reproducibility was assessed, and the morphologic features were correlated with PCI. Relationships between pathologists’ interpretations, morphologic features, and PCI were evaluated using hierarchical clustering. Although the diagnosis of PCI was relatively uniform with a majority agreement (>67%) reached in 16/20 slides, overall interobserver reproducibility was only moderate (kappa=0.601). While all 4 morphologic features were sensitive for PCI, polypoid configuration of the tumor into the renal pelvis and the tumor eroding through the renal pelvic urothelium were most specific (90%, 100%, respectively). Although we show general consensus among genitourinary pathologists on PCI assessment, clarifying the diagnostic guidelines with specific criteria should be included in pathologic staging systems.
Penetrating Bladder Trauma Leading to a Rectovesical Fistula: A Rare Complication of Bicycle Handlebar Injury in a Paediatric Patient
Kavirayani, Vaishnavi , Pai, Nitin G , Kumar, Vijay , Thotan, Sundeep Payyanur

Journal of Indian Association of Pediatric Surgeons | July 30, 2025 | Volume: 30 | Issue: 6 | Pages: 794-796

10.4103/jiaps.jiaps_99_25 | PMID 41293506 Get It

A BSTRACT An adolescent boy presented with a history of penetrating trauma from a bicycle handlebar injury to the left lower abdomen. A computed tomography (CT) scan and a diagnostic laparoscopy showed extraperitoneal bladder rupture, which was repaired. In the postoperative period, a micturating cystourethrogram revealed a rectovesical fistula (RVF), which was managed conservatively with a Foley catheter. This case depicts a rare complication of RVF in a case of penetrating trauma abdomen managed conservatively with a unique mechanism of injury.
Self‐Expanding Aortic Endoprosthesis for Conduit Preparation Prior to Transcatheter Pulmonary Valve Replacement
Krebushevski, Kaitlyn , Cabalka, Allison K. , Pollak, Peter , Yu, Liwei , Anderson, Jason H. , Pollak, Peter M , Cabalka, Allison , Anderson, Jason

Catheterization and Cardiovascular Interventions | July 30, 2025 | Volume: 106 | Issue: 4 | Pages: 2244-2251

10.1002/ccd.70039 | PMID 40734327 Get It

ABSTRACT Background Preparation of the right ventricular outflow tract (RVOT) using covered stent placement is a common preparatory step for transcatheter pulmonary valve replacement (TPVR) to reduce the risk of disruption associated with dilating calcified RVOT conduits. Aim We present a novel method employing a self‐expanding covered aortic endoprosthesis and discuss its advantages as an alternative strategy. Methods Patients with congenital heart disease undergoing RVOT conduit preparation with the GORE TAG Thoracic Branch Endoprosthesis Extender (W.L. Gore & Associates, Newark, DE) followed by TPVR, were prospectively enrolled in a dedicated database. To date, 14 patients have been included. Data on demographics, diagnoses, procedural details, hemodynamic parameters, and outcomes were analyzed. Results Fourteen patients (median age: 35 years [range: 18–79]; 57% female) successfully underwent endograft placement immediately before TPVR. Treated conduits included pulmonary homografts ( n = 8), surgical bioprostheses ( n = 2), Hancock conduit ( n = 1), Contegra conduit ( n = 1), native RVOT ( n = 1), and Melody valve within a surgical bioprosthesis ( n = 1). Most patients presented with mixed stenosis and regurgitation ( n = 9), with the remaining having stenosis ( n = 4) or regurgitation ( n = 1). Valves implanted post‐preparation included the Sapien S3 valve (Edwards Lifesciences, Irvine, CA) ( n = 10) and the Melody valve (Medtronic, Minneapolis, MN) ( n = 5). Significant reductions in RVOT systolic gradient were observed (median 34 mmHg pre‐procedure to 3 mmHg post‐procedure), along with marked conduit expansion (median diameter 13 mm pre‐procedure to 25.5 mm post‐procedure). No complications were reported. Conclusions This study highlights the feasibility of a self‐expanding aortic endoprosthesis for RVOT preparation before TPVR. Further comparative study is warranted. Procedural success was achieved in all cases.
Mitochondrial complex I deficiency induces Alzheimer's disease–like signatures that are reversible by targeted therapy
Gao, Huanyao , Jensen, Kate , Nesbitt, Jarred J., Ostroot, Mark , Wiley, Jesse C. , Trushin, Sergey , Funk, Cory C. , Nesbitt, Jarred, Cary, Gregory A. , Watzlawik, Jens O. , Springer, Wolfdieter , Galkin, Alexander , Baloni, Priyanka , Trushina, Eugenia

Alzheimer's & Dementia | July 30, 2025 | Volume: 21 | Issue: 8 | Pages: No page available

10.1002/alz.70519 | PMID 40731203 Get It

Abstract INTRODUCTION Mitochondrial dysfunction is implicated in Alzheimer's disease (AD), but whether it drives AD‐associated changes is unclear. We assessed transcriptomic alterations in the brains of Ndufs4 −/− mice, a model of mitochondrial complex I (mtCI) deficiency, and evaluated the therapeutic effects of the neuroprotective mtCI inhibitor CP2. METHODS Cortico‐hippocampal tissue from Ndufs4 −/− and wild‐type mice was subjected to transcriptomic analysis, followed by cross‐species comparisons to human late‐onset AD and familial AD mouse datasets. RESULTS Knockout of Ndufs4 ‐mediated mtCI deficiency disrupted mitochondrial homeostasis, energy metabolism, and synaptic gene expression, recapitulating transcriptomic signatures of AD. CP2 treatment partially reversed these changes, with female Ndufs4 −/− mice showing greater compensatory adaptations and treatment responses. DISCUSSION Loss of mtCI activity alone is sufficient to induce AD‐like molecular changes in the brain, independent of amyloid beta or phosphorylated tau. CP2‐mediated rescue highlights the potential of targeting mitochondria as a therapeutic strategy for AD. Sex‐specific responses suggest important considerations for personalized therapeutics. Highlights Activity of mitochondrial complex I (mtCI) affects broad mitochondrial and neuronal transcriptional networks. A reduction of mtCI activity is sufficient to induce transcriptomic changes reminiscent of those observed in late‐onset Alsheimer's disease (AD) patients and familial mouse models of AD. Pharmacological targeting of mtCI mediates neuroprotective signaling. Male and female mice have differential responses to the loss of mtCI activity and to the mitochondria‐targeted therapeutics. Mitochondria play a key role in AD development and treatment.
Endoscopic ultrasound-guided pancreatic ring drainage via a pancreaticoenteric fistula
Law, Ryan , Khan, Rishad

Endoscopy | July 29, 2025 | Volume: 57 | Issue: S 01 | Pages: E831-E832

10.1055/a-2638-3110 | PMID 40730330 Get It